[TLX] QoQ Quarter Result on 31-Dec-2023 [#Q4]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
29-Dec-2023
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 236.39%
YoY- 158.85%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/12/23 30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 CAGR
Revenue 188,963 281,713 220,834 136,049 24,047 4,686 2,910 301.43%
PBT 9,143 15,387 -12,300 -27,919 -70,703 -61,993 -37,046 -
Tax -2,537 -4,144 2,020 5,269 188 -13,997 -4,532 -17.56%
NP 11,680 19,531 -14,320 -33,188 -70,891 -47,996 -32,514 -
Tax Rate 27.75% 26.93% - - - - - -
Total Cost 177,283 262,182 235,154 169,237 94,938 52,682 35,424 70.96%
Ratio Analysis
30/06/24 31/12/23 30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 CAGR
NP Margin 6.18 6.93 -6.48 -24.39 -294.80 -1,024.24 -1,117.32 -
Per Share
30/06/24 31/12/23 30/06/23 31/12/22 30/06/22 31/12/21 30/06/21 CAGR
EPS 0.04 0.06 -0.05 -0.10 -0.23 -0.17 -0.12 -
EPS Diluted 0.03 0.06 -0.05 -0.10 -0.23 -0.17 -0.12 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.